Literature DB >> 26347456

Poor specificity of urinary cryptococcal antigen testing: Reply to Drain et al. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.

M W Tenforde1,2, N Longley3, D B Meya4,5, D R Boulware4, G Meintjes6, I Goercke7, T S Harrison3, J N Jarvis1,8,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26347456      PMCID： PMC5816972          DOI： 10.1111/hiv.12319

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  9 in total

1.  Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Authors:  David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

2.  Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

Authors:  Sayoki Mfinanga; Duncan Chanda; Sokoine L Kivuyo; Lorna Guinness; Christian Bottomley; Victoria Simms; Carol Chijoka; Ayubu Masasi; Godfather Kimaro; Bernard Ngowi; Amos Kahwa; Peter Mwaba; Thomas S Harrison; Saidi Egwaga; Shabbar Jaffar
Journal:  Lancet       Date:  2015-03-10       Impact factor: 79.321

3.  Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Authors:  Joseph N Jarvis; Stephen D Lawn; Monica Vogt; Nonzwakazi Bangani; Robin Wood; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

4.  Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases.

Authors:  Joseph N Jarvis; Graeme Meintjes; Anthony Williams; Yolande Brown; Tom Crede; Thomas S Harrison
Journal:  BMC Infect Dis       Date:  2010-03-15       Impact factor: 3.090

Review 5.  Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy.

Authors:  David Meya; Radha Rajasingham; Elizabeth Nalintya; Mark Tenforde; Joseph N Jarvis
Journal:  Curr Trop Med Rep       Date:  2015

6.  Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.

Authors:  Darlisha A Williams; Tadeo Kiiza; Richard Kwizera; Reuben Kiggundu; Sruti Velamakanni; David B Meya; Joshua Rhein; David R Boulware
Journal:  Clin Infect Dis       Date:  2015-04-01       Impact factor: 9.079

7.  Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.

Authors:  P K Drain; J M Kleene; S M Coleman; E Losina; J N Katz; J Giddy; D Ross; K A Freedberg; I V Bassett
Journal:  HIV Med       Date:  2015-05-11       Impact factor: 3.180

8.  Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100.

Authors:  Richard Kwizera; Joyce Nguna; Agnes Kiragga; Jesca Nakavuma; Radha Rajasingham; David R Boulware; David B Meya
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

9.  Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania.

Authors:  Kinanga A Magambo; Samuel E Kalluvya; Shikha W Kapoor; Jeremiah Seni; Awilly A Chofle; Daniel W Fitzgerald; Jennifer A Downs
Journal:  J Int AIDS Soc       Date:  2014-08-08       Impact factor: 5.396
  9 in total
  2 in total

Review 1.  Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Authors:  Peter R Williamson; Joseph N Jarvis; Anil A Panackal; Matthew C Fisher; Síle F Molloy; Angela Loyse; Thomas S Harrison
Journal:  Nat Rev Neurol       Date:  2016-11-25       Impact factor: 42.937

2.  Preheating of urine improves the specificity of urinary cryptococcal antigen testing using the lateral flow assay.

Authors:  Fábio Brito-Santos; Marcela de Faria Ferreira; Luciana Trilles; Mauro de Medeiros Muniz; Valdiléa Gonçalves Veloso Dos Santos; Filipe Anibal Carvalho-Costa; Wieland Meyer; Bodo Wanke; Márcia Dos Santos Lazéra
Journal:  PLoS Negl Trop Dis       Date:  2017-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.